arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Elevance Health, Inc.

ELV Health Care Medical Specialities
$407.50
▲ +0.0% Today
as of Sep 4, 16:48 ET
Last 30 days +7.70% Jul 27 → Sep 04
$372.72 $384.02 $395.31 $406.60 $417.90 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$411.12
High
$414.46
Low
$406.34
Volume
$1M
Avg Vol
$2M
Mkt Cap
$82.3B
P/E (TTM)
19.69
Beta
—
52w High
$436.24
52w Low
$274.84
Div Yield
—
Shares Out
$217M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 25 ▼ 0
Sep 4 · 17:08 RATING Simply Wall St. neutral
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
Sep 2 · 11:57 Barchart neutral
How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
Sep 1 · 14:19 Insider Monkey neutral
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$275
$436
82% of range
Avg surprise (last 2)
-1.7%
Avg reaction (last 2)
-5.0%
50% positive
Latest IV / EM
26%
EM ±4.0% · $410 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$4.36$6.26$8.17$10.07$11.97 Actual $8.30Actual $7.79Actual $5.45Actual $9.59Actual $9.85Actual $4.36Actual $11.97Est $11.97Actual $8.84Est $9.16Actual $5.32Actual $8.00Actual $6.71 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$13.3B$26.6B$39.9B$53.2B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $6.71 — — — — financials
Tue Mar 31, 2026Mar 2026 $8.00 — — — — financials
Tue Sep 30, 2025Sep 2025 $5.32 — — — — financials
Thu Jul 17, 2025Jun/2025 $8.84 $9.16 -3.5% — -12.2% earnings
Tue Apr 22, 2025Mar/2025 $11.97 $11.97 0.0% — +2.3% earnings
Mon Sep 30, 2024Sep 2024 $4.36 — — — — financials
Sun Jun 30, 2024Jun 2024 $9.85 — — — — financials
Sun Mar 31, 2024Mar 2024 $9.59 — — — — financials
Sat Sep 30, 2023Sep 2023 $5.45 — — — — financials
Fri Jun 30, 2023Jun 2023 $7.79 — — — — financials
Fri Mar 31, 2023Mar 2023 $8.30 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$50.47B$50.18B—$50.71B$49.78B$48.89B—$45.11B
Cost of revenue$5.49B$5.46B—$5.38B$5.29B$4.98B—$5.09B
Gross profit————————
Operating income$1.76B$2.09B—$1.29B$2.42B$3.17B—$1.41B
Net income$1.46B$1.76B—$1.19B$1.74B$2.18B—$1.02B
EPS (diluted)$6.71$8.00—$5.32$7.72$9.61—$4.36

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$10.23B$9.66B$9.49B$8.71B$8.56B$7.50B$8.29B$7.87B
Inventory————————
Total current assets$67.18B$67.03B$63.00B$63.78B$63.32B$61.12B$58.94B$62.85B
Total assets$126.44B$125.83B$121.49B$122.75B$121.94B$119.72B$116.89B$116.53B
Long-term debt$30.67B$30.77B$30.80B$31.17B$28.18B$28.11B$29.22B$24.69B
Total liabilities$81.42B$81.78B$77.47B$78.67B$78.09B$77.10B$75.46B$72.65B
Total equity$44.88B$44.04B$43.88B$43.95B$43.85B$42.62B$41.31B$43.88B

Implied volatility — last 90 days

24%40%56%73%89% Jun 07 — IV 40% · EM ±5.5%Jun 08 — IV 38% · EM ±5.1%Jun 09 — IV 39% · EM ±4.9%Jun 10 — IV 34% · EM ±4.0%Jun 11 — IV 32% · EM ±3.6%Jun 12 — IV 32% · EM ±3.3%Jun 15 — IV 38% · EM ±2.8%Jun 16 — IV 40% · EM ±2.4%Jun 17 — IV 48% · EM ±2.0%Jun 19 — IV 37% · EM ±8.2%Jun 22 — IV 38% · EM ±7.9%Jun 23 — IV 38% · EM ±7.8%Jun 24 — IV 41% · EM ±8.3%Jun 25 — IV 39% · EM ±7.6%Jun 26 — IV 38% · EM ±7.4%Jun 29 — IV 45% · EM ±7.9%Jun 30 — IV 41% · EM ±7.1%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 39% · EM ±6.2%Jul 03 — IV 40% · EM ±6.2%Jul 06 — IV 43% · EM ±6.0%Jul 07 — IV 54% · EM ±7.1%Jul 08 — IV 55% · EM ±6.9%Jul 09 — IV 61% · EM ±7.2%Jul 10 — IV 60% · EM ±6.7%Jul 13 — IV 85% · EM ±7.1%Jul 14 — IV 89% · EM ±6.5%Jul 15 — IV 57% · EM ±3.4%Jul 16 — IV 32% · EM ±1.3%Jul 20 — IV 35% · EM ±8.2%Jul 21 — IV 33% · EM ±7.7%Jul 22 — IV 32% · EM ±7.4%Jul 23 — IV 33% · EM ±7.5%Jul 24 — IV 33% · EM ±7.3%Jul 27 — IV 34% · EM ±7.1%Jul 28 — IV 33% · EM ±6.8%Jul 29 — IV 33% · EM ±6.6%Jul 30 — IV 32% · EM ±6.3%Jul 31 — IV 33% · EM ±6.3%Aug 03 — IV 33% · EM ±5.8%Aug 04 — IV 34% · EM ±5.8%Aug 05 — IV 35% · EM ±5.8%Aug 06 — IV 33% · EM ±5.3%Aug 07 — IV 32% · EM ±4.9%Aug 10 — IV 33% · EM ±4.6%Aug 11 — IV 33% · EM ±4.3%Aug 12 — IV 32% · EM ±4.0%Aug 13 — IV 32% · EM ±3.7%Aug 14 — IV 29% · EM ±3.3%Aug 17 — IV 38% · EM ±3.2%Aug 18 — IV 41% · EM ±3.0%Aug 19 — IV 35% · EM ±2.0%Aug 20 — IV 49% · EM ±2.0%Aug 24 — IV 29% · EM ±6.1%Aug 25 — IV 26% · EM ±5.4%Aug 26 — IV 27% · EM ±5.4%Aug 27 — IV 26% · EM ±5.1%Aug 28 — IV 27% · EM ±5.1%Aug 31 — IV 24% · EM ±4.3%Sep 01 — IV 31% · EM ±5.3%Sep 02 — IV 26% · EM ±4.4%Sep 03 — IV 25% · EM ±4.0%Sep 04 — IV 26% · EM ±4.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in